Aug 13 (Reuters) - Grail Inc (GRAL.O), opens new tab said on Tuesday it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test ...
Sphera Funds added 374,847 shares of Syndax Pharmaceuticals in the fourth quarter. The quarter-end position value rose by $10.06 million, reflecting both trading and price movement. The post-trade ...
A cancer drug developer has rocked Wall Street by implementing what is perhaps the most audacious crypto treasury strategy we have seen from a traditional biotech firm. MAIA Biotechnology (NYSE ...
Bristol Myers BMY announced that it has entered into a definitive merger agreement to acquire radiopharmaceutical therapeutics (RPT) company RayzeBio RYZB for $62.50 per share in cash, amounting to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results